Michael S. Abrams its chief financial officer.
In alignment with the company’s succession plan, Abrams joins Arch’s financial team in the role previously held by Richard Davis. Davis will remain with the company during a transition period, which will end on June 30, after which he will support the company in a consulting role through Dec. 31.
Abrams has more than 25 years of experience as a chief financial officer to numerous public and private companies; principal investor; investment banker; merchant banker; strategic and financial adviser; and board member. His capabilities span a broad range of activities with a particular expertise in the areas of operational management, complex financial engineering, financial advisory and capital markets strategy primarily for companies in the technology and healthcare sectors.
Paul Brassil of
Medfield has joined the company as senior vice president/chief information officer and will oversee PCU’s information technology and digital innovation efforts.
Brassil has more than 25 years of experience in the information technology leadership field with entities such as Commonwealth Medicine (a division of UMass Medical School), the Federal Reserve Bank of Boston, EMC Corp. and Siemens IT Solutions and Services Inc.
He holds an MS in computer information systems from Bentley University in
Waltham and a BA in Business Administration from Bridgewater State University.
Brassil s community involvement spans initiatives focused on workforce development and industry leadership serving as a member of the Tech Hire Advisory Group of Boston’s Private Industry Council (comprised of Boston CIOs developing summer intern programs for low/moderate income students in the Boston Public Schools); an adviser for Fintech Women (helping women in banking/finance/fintech a
Dr Mahavir Prashad joins Sai Life Sciences as VP, Early Phase Process Development
Dr Mahavir Prashad joins Sai Life Sciences as VP, Early Phase Process Development
11 February 2021 | News Dr Prashad is a recognised leader in chemical process R&D and leveraging green chemistry principles and modern technologies in API synthesis. He possesses an excellent scientific track record through 94 publications, 4 review articles, 1 book chapter, 71 patent/applications, and 10 invited lectures at scientific conferences
Source: prnasia.com
Sai Life Sciences announced the addition of Dr Mahavir Prashad, an acknowledged scientific leader and industry veteran, to its scientific leadership team as Vice President of Early Phase Process Development. With over three decades of experience in advanced research, and roles of increasing responsibility in one of the world s leading pharmaceutical companies, Dr Prashad will provide impetus to Sai Life Sciences growing capabilities and help ac
Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences
HYDERABAD, India, Feb. 11, 2021 /PRNewswire/ Sai Life Sciences, one of India s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the addition of Dr. Mahavir Prashad, an acknowledged scientific leader and industry veteran, to its scientific leadership team as Vice President of Early Phase Process Development. With over three decades of experience in advanced research, and roles of increasing responsibility in one of the world s leading pharmaceutical companies, Dr. Prashad will provide impetus to Sai Life Sciences growing capabilities and help accelerate the drug development programmes of its customers.